EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Potential of Cardiac Biomarkers in Differentiating Disease Subtypes in Patients with Systemic Sclerosis: Focus on GDF15, MR-pro ANP, and suPAR

Olga Gumkowska-Sroka, Anna Chudek iD, Aleksander Owczarek, Kornelia Kuźnik-Trocha iD, Kacper Kotyla, Jan Kurdybacha, Jerzy Chudek iD, Katarzyna Komosińska-Vassev iD, Katarzyna Winsz-Szczotka iD, Krystyna Olczyk iD, Przemysław Kotyla iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26093938 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Olga Gumkowska-Sroka und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine Rheumatology and Clinical Immunology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-635 …. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Biomarkers, Atrial Natriuretic Factor, Scleroderma, Systemic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical University of Silesia, Katowice, Poland, Medical University of Silesia Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Systemic sclerosis, a connective tissue disease of unknown etiology and unpredictable outcomes, is characterized by the fibrosis of the skin and internal organs, vasculopathy, and immune system dysregulation. The disease is classified into two main subtypes, which differ in clinical presentation, complications, and prognosis. While several biomarkers have been proposed to distinguish between these subtypes, none have achieved high sensitivity and specificity. The search for dependable markers that can differentiate between the two primary subtypes of systemic sclerosis continues. To address this gap, our study evaluated the utility of novel cardiac biomarkers, including growth differentiation factor 15 (GDF15), galectin-3, mid-regional pro-atrial natriuretic peptide (MR-proANP), glutathione S-transferase π, mid-regional adrenomedullin, and soluble urokinase plasminogen activator receptor (suPAR), in a cohort of 79 patients with both lcSSc and dSSc subtypes. The results demonstrated a significant elevation of GDF15 (medians: 2.07 vs. 1.10 ng/L; p < 0.001) and MR-proANP (92.55 vs. 65.60 pmol/L; p < 0.05) levels in SSc patients compared to healthy controls. Moreover, GDF15 (1.65 vs. 2.34 ng/mL; p < 0.05), MR-proANP (80.87 vs. 109.27 pmol/L; p < 0.05), and suPAR (1.83 vs. 2.44 ng/mL; p < 0.05) levels were notably higher in patients with dSSc compared to those with lcSSc. In the ROC analysis, only GDF-15, MR-proANP, and suPAR proved to have a statistically significant area under the curve (AUC). Patients with the GDF-15 ≥ 2182 ng/mL, MR-prANP ≥ 85.808 pmol/L, and suPAR ≥ 2.315 ng/mL have more than six-, eight-, and seven-times-higher odds for dcSSc, respectively. These findings highlight the potential of GDF15, suPAR, and MR-proANP as biomarkers for differentiating between the two main subtypes of systemic sclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Growth Differentiation Factor 15BiomarkersAtrial Natriuretic FactorScleroderma, SystemicReceptors, Urokinase Plasminogen ActivatorProtein PrecursorsHumansMaleFemaleMiddle AgedAgedAdultROC CurveAdrenomedullin

Stichwörter der Autor:innen

GDF15MR-proANPgalectin-3glutathione S-transferase πheart biomarkersmid-regional adrenomedullinsuPARsystemic sclerosis

Substanzen

Growth Differentiation Factor 15BiomarkersGDF15 protein, humanAtrial Natriuretic FactorReceptors, Urokinase Plasminogen ActivatorAdrenomedullinProtein Precursorsmidregional pro-atrial natriuretic peptide, human

Autor:innen und Institutionen

  • Department of Internal Medicine Rheumatology and Clinical Immunology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-635 Katowice, Poland.
  • Department of Rheumatology and Clinical Immunology, Voivodeship Hospital, No. 5, 41-200 Sosnowiec, Poland.
  • Health Promotion and Obesity Management Unit, Department of Pathophysiology, Faculty of Medical Sciences in Katowice, Medical University of Silesia, 40-752 Katowice, Poland.
  • Department of Clinical Chemistry and Laboratory Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia, 41-200 Katowice, Poland.
  • Department of Internal Medicine and Oncological Chemotherapy, Medical University of Silesia, 40-029 Katowice, Poland.

ORCID-Profile: Anna Chudek, Kornelia Kuźnik-Trocha, Jerzy Chudek, Katarzyna Komosińska-Vassev, Katarzyna Winsz-Szczotka, Krystyna Olczyk, Przemysław Kotyla

Förderung

  • Medical University of Silesia, Katowice, Poland
  • Medical University of Silesia Poland

Zitieren

APA

Gumkowska-Sroka, O., Chudek, A., Owczarek, A., Kuźnik-Trocha, K., Kotyla, K., Kurdybacha, J., Chudek, J., Komosińska-Vassev, K., Winsz-Szczotka, K., Olczyk, K., & Kotyla, P. (2025). The Potential of Cardiac Biomarkers in Differentiating Disease Subtypes in Patients with Systemic Sclerosis: Focus on GDF15, MR-pro ANP, and suPAR. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26093938

Vancouver

Gumkowska-Sroka O, Chudek A, Owczarek A, Kuźnik-Trocha K, Kotyla K, Kurdybacha J, et al. The Potential of Cardiac Biomarkers in Differentiating Disease Subtypes in Patients with Systemic Sclerosis: Focus on GDF15, MR-pro ANP, and suPAR. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26093938

BibTeX
@article{GumkowskaSroka2025,
  author = {Gumkowska-Sroka, Olga and Chudek, Anna and Owczarek, Aleksander and Kuźnik-Trocha, Kornelia and Kotyla, Kacper and Kurdybacha, Jan and Chudek, Jerzy and Komosińska-Vassev, Katarzyna and Winsz-Szczotka, Katarzyna and Olczyk, Krystyna and Kotyla, Przemysław},
  title = {The Potential of Cardiac Biomarkers in Differentiating Disease Subtypes in Patients with Systemic Sclerosis: Focus on GDF15, MR-pro ANP, and suPAR},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26093938}
}
Kostenlos starten →